NCT00085930View on ClinicalTrials.gov

Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

January 31, 2010

Study Completion Date

December 31, 2025

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

EBV specific CTLs

CTLs: 2x10e7 cells/m2

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
collaborator

Center for Cell and Gene Therapy, Baylor College of Medicine

OTHER

lead

Baylor College of Medicine

OTHER